Results 261 to 270 of about 448,633 (304)

ICONS

2011
Eine Analyse der Profilbilder markanter Köpfe aus der deutschen Digital-Szene (ohne Sascha Lobo) – warum sie wie wirken und was daraus für die Wahl des eigenen Profilbildes abgeleitet werden kann.
openaire   +1 more source

Impacts of the January 2022 Tonga Volcanic Eruption on the Ionospheric Dynamo: ICON‐MIGHTI and Swarm Observations of Extreme Neutral Winds and Currents

Geophysical Research Letters, 2022
Brian Harding, Yen-Jung J Wu, Patrick Alken   +2 more
exaly  

Is an icon iconic?

Language, 2008
openaire   +1 more source

Icon/image

Material Religion, 2011
openaire   +1 more source

ICON 2019—International Scientific Tendinopathy Symposium Consensus: There are nine core health-related domains for tendinopathy (CORE DOMAINS): Delphi study of healthcare professionals and patients

British Journal of Sports Medicine, 2020
Bill T Vicenzino, Robert-Jan de Vos, Hakan Alfredson   +2 more
exaly  

Validation of ICON‐MIGHTI Thermospheric Wind Observations: 2. Green‐Line Comparisons to Specular Meteor Radars

Journal of Geophysical Research: Space Physics, 2021
Brian Harding, Jorge Chau, Maosheng He
exaly  

The ICON Earth System Model Version 1.0

Journal of Advances in Modeling Earth Systems, 2022
Johann H Jungclaus, Hauke Schmidt, Victor Brovkin   +2 more
exaly  

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial

Lancet Oncology, The, 2020
Sarah P Blagden, Andrew Dean, Jae-Weon Kim   +2 more
exaly  

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Lancet Oncology, The, 2015
Amit M Oza, Andrew C Embleton, Jonathan A Ledermann   +2 more
exaly  

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

Lancet, The, 2019
Andrew R Clamp, Elizabeth C James, Iain A Mcneish   +2 more
exaly